(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 4.63% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.18%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.
Avanos Medical's revenue in 2024 is $673,300,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2024 to be $31,937,818,220, with the lowest AVNS revenue forecast at $31,880,064,480, and the highest AVNS revenue forecast at $32,027,914,054. On average, 3 Wall Street analysts forecast AVNS's revenue for 2025 to be $33,971,350,507, with the lowest AVNS revenue forecast at $33,538,751,893, and the highest AVNS revenue forecast at $34,651,781,970.
In 2026, AVNS is forecast to generate $35,522,708,369 in revenue, with the lowest revenue forecast at $35,519,936,190 and the highest revenue forecast at $35,525,480,549.